Ch282-5

MedChem Express

Ch282-5

9

Research Use Only

C34H34N2Na2O14S2

804.75

Ch282-5 is an orally active inhibitor targeting the Bcl-2 protein, inducing mitochondria-dependent apoptosis ( Apoptosis ) by disrupting mitophagy and the mTOR pathway. Ch282-5 exhibits antiproliferative activity against colorectal cancer cells both in vitro and in vivo, and it also inhibits metastasis. Additionally, Ch282-5 enhances Oxaliplatin (HY-17371)-induced autophagy ( Autophagy ) by downregulating the Mcl-1 protein and increasing platelet count, alleviating adverse effects of Navitoclax (HY-10087) [1] .

CC(C1=C(O)C(O)=C(/C=N/CCS(=O)(O[Na])=O)C(C(C(C(C2=O)=C(C)C(C3=C2C(/C=N/CCS(=O)(O[Na])=O)=C(O)C(O)=C3C(C)C)=O)=C4C)=O)=C1C4=O)C

12352200